Greater risk for autism spectrum disorders has been reported among mothers that have used selective serotonin reuptake inhibitors during pregnancy.
However, others did not find an association between the use of selective serotonin reuptake inhibitors during pregnancy and risk for autism in offspring.
Also, selective serotonin reuptake inhibitor use during pregnancy were associated with a greater number of gastrointestinal complaints in children with autism spectrum disorders.
